JP2022500382A5 - - Google Patents

Info

Publication number
JP2022500382A5
JP2022500382A5 JP2021513309A JP2021513309A JP2022500382A5 JP 2022500382 A5 JP2022500382 A5 JP 2022500382A5 JP 2021513309 A JP2021513309 A JP 2021513309A JP 2021513309 A JP2021513309 A JP 2021513309A JP 2022500382 A5 JP2022500382 A5 JP 2022500382A5
Authority
JP
Japan
Prior art keywords
seq
residues
antibody
sle
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021513309A
Other languages
English (en)
Japanese (ja)
Other versions
JP7560445B2 (ja
JP2022500382A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/050262 external-priority patent/WO2020055768A1/en
Publication of JP2022500382A publication Critical patent/JP2022500382A/ja
Publication of JP2022500382A5 publication Critical patent/JP2022500382A5/ja
Application granted granted Critical
Publication of JP7560445B2 publication Critical patent/JP7560445B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021513309A 2018-09-10 2019-09-09 膵炎を処置するための方法 Active JP7560445B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862729354P 2018-09-10 2018-09-10
US62/729,354 2018-09-10
PCT/US2019/050262 WO2020055768A1 (en) 2018-09-10 2019-09-09 Methods for treating pancreatitis

Publications (3)

Publication Number Publication Date
JP2022500382A JP2022500382A (ja) 2022-01-04
JP2022500382A5 true JP2022500382A5 (cg-RX-API-DMAC7.html) 2022-09-20
JP7560445B2 JP7560445B2 (ja) 2024-10-02

Family

ID=69776851

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021513309A Active JP7560445B2 (ja) 2018-09-10 2019-09-09 膵炎を処置するための方法

Country Status (13)

Country Link
US (1) US12378320B2 (cg-RX-API-DMAC7.html)
EP (1) EP3849605A4 (cg-RX-API-DMAC7.html)
JP (1) JP7560445B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210073515A (cg-RX-API-DMAC7.html)
CN (2) CN113056286B (cg-RX-API-DMAC7.html)
AU (1) AU2019337564A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021004444A2 (cg-RX-API-DMAC7.html)
CA (1) CA3112382A1 (cg-RX-API-DMAC7.html)
CL (2) CL2021000585A1 (cg-RX-API-DMAC7.html)
IL (1) IL281343A (cg-RX-API-DMAC7.html)
MX (1) MX2021002761A (cg-RX-API-DMAC7.html)
SG (1) SG11202102416SA (cg-RX-API-DMAC7.html)
WO (1) WO2020055768A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020055768A1 (en) 2018-09-10 2020-03-19 Cold Spring Harbor Laboratory Methods for treating pancreatitis
US20250297027A1 (en) * 2021-01-12 2025-09-25 Yeda Research And Development Co. Ltd. Antibodies to cancer glycosylation and uses thereof
CA3214598A1 (en) * 2021-03-26 2022-09-29 BioNTech SE Combination therapy with an anti-ca19-9 antibody and folfirinox in the treatment of cancer
US12661076B2 (en) * 2024-03-26 2026-06-23 Hepatiq, Inc. Determining pancreas disease using functional imaging

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4471057A (en) * 1981-06-30 1984-09-11 The Wistar Institute Detection of colorectal carcinoma
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
US5051448A (en) 1984-07-24 1991-09-24 The Mclean Hospital Corporation GABA esters and GABA analog esters
US4704355A (en) 1985-03-27 1987-11-03 New Horizons Diagnostics Corporation Assay utilizing ATP encapsulated within liposome particles
JPS63159763A (ja) * 1986-12-24 1988-07-02 Fujirebio Inc 逆受身凝集反応試薬
CA2025907A1 (en) 1989-09-21 1991-03-22 Franklin D. Collins Method of transporting compositions across the blood brain barrier
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
US5559103A (en) 1993-07-21 1996-09-24 Cytel Corporation Bivalent sialyl X saccharides
US5576423A (en) 1994-12-02 1996-11-19 Schering Corporation Antibodies to the slam protein expressed on activated T cells
US7238715B2 (en) 2002-12-06 2007-07-03 The Feinstein Institute For Medical Research Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
EP1924276A4 (en) 2005-08-05 2009-07-22 Araim Pharmaceuticals Inc Antiperspirant peptides and their uses
FI20070853A0 (fi) 2007-11-09 2007-11-09 Glykos Finland Oy Glykaania sitovat monoklonaaliset vasta-aineet
WO2009094172A2 (en) 2008-01-22 2009-07-30 Araim Pharmaceuticals, Inc. Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
WO2010017500A2 (en) 2008-08-08 2010-02-11 Immunomedics, Inc. Anti-pancreatic cancer antibodies
PL2970422T3 (pl) 2013-03-15 2018-09-28 F.Hoffmann-La Roche Ag Polipeptydy IL-22 i białka fuzyjne IL-22 Fc i sposoby zastosowania
CN105517561A (zh) 2013-07-17 2016-04-20 阿拉伊姆药品公司 预防和治疗组织损伤相关疾病和病症的组织保护肽和肽类似物
CN105764526B (zh) 2013-08-26 2020-12-15 生物技术研发公司 编码抗唾液酸化路易斯a抗原的人抗体的核酸
CN104623639A (zh) 2013-11-07 2015-05-20 健能隆医药技术(上海)有限公司 白介素22二聚体在制备治疗胰腺炎药物中的应用
RS60593B1 (sr) 2014-01-24 2020-08-31 Ngm Biopharmaceuticals Inc Antitela koja vezuju domen 2 beta-kloto i postupci za njihovu upotrebu
US10800843B2 (en) 2015-07-29 2020-10-13 Ngm Biopharmaceuticals, Inc. Beta klotho-binding proteins
EP3448874A4 (en) * 2016-04-29 2020-04-22 Voyager Therapeutics, Inc. COMPOSITIONS FOR TREATING A DISEASE
WO2020055768A1 (en) 2018-09-10 2020-03-19 Cold Spring Harbor Laboratory Methods for treating pancreatitis

Similar Documents

Publication Publication Date Title
JP2024150751A5 (cg-RX-API-DMAC7.html)
KR102757960B1 (ko) 간세포암(hepatocellular carcinoma: HCC)에 대한 면역 치료
AU2025203751A9 (en) Anti-BCMA heavy chain-only antibodies
CA3146341A1 (en) Bispecific anti lrrc15 and cd3epsilun antibudies
CN103172742A (zh) 人cd22特异性抗体及其治疗和诊断应用
JP2012515746A (ja) 抗cd160モノクローナル抗体及びその使用
KR20230008775A (ko) Cd3 및 cd20에 대한 이중특이적 항체
JP2010504755A5 (cg-RX-API-DMAC7.html)
WO2014198748A1 (en) Anti-her2 single domain antibodies, polypeptides comprising thereof and their use for treating cancer
US20210355229A1 (en) An anti-ox40 antibody, antigen-binding fragment thereof, and the pharmaceutical use
TWI855014B (zh) Muc18特異性抗體
JP2022549172A5 (cg-RX-API-DMAC7.html)
US12173081B2 (en) CD19/CD38 multispecific antibodies
CN112480259B (zh) 抗tnfr2抗体及其用途
JP2023542291A (ja) びまん性大細胞型b細胞リンパ腫を治療するための併用療法におけるcd3及びcd20に対する二重特異性抗体
US20240092875A1 (en) Sars-cov-2 antibodies for treatment and prevention of covid-19
JP2020527152A5 (cg-RX-API-DMAC7.html)
KR20220012856A (ko) 항 pd―l1 항체 및 그의 용도
JP2024540395A (ja) Covid-19を治療及び予防するための組成物
JP2023537078A5 (cg-RX-API-DMAC7.html)
CN115957321A (zh) 一种抗her2抗体在制备治疗癌症的药物中的用途
TW202321303A (zh) 抗pla2r自體抗體媒介膜性腎病變之治療
KR20240072932A (ko) B7-h3에 특이적으로 결합하는 항체
IL319999A (en) Bispecific antibodies against CD3 and CD20 - for the treatment of Richter syndrome
JP2025516805A (ja) 固形腫瘍を治療する方法